KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Amortization - Intangibles (2021 - 2025)

Pacific Biosciences Of California (PACB) has 5 years of Amortization - Intangibles data on record, last reported at $833000.0 in Q4 2025.

  • For Q4 2025, Amortization - Intangibles rose 120.91% year-over-year to $833000.0; the TTM value through Dec 2025 reached $364.5 million, up 3975.36%, while the annual FY2025 figure was $364.5 million, 3780.99% up from the prior year.
  • Amortization - Intangibles reached $833000.0 in Q4 2025 per PACB's latest filing, roughly flat from $833000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $362.0 million in Q1 2025 and bottomed at -$4.0 million in Q4 2024.
  • Average Amortization - Intangibles over 5 years is $25.3 million, with a median of $833000.0 recorded in 2025.
  • Peak YoY movement for Amortization - Intangibles: plummeted 397.56% in 2022, then soared 6475.41% in 2025.
  • A 5-year view of Amortization - Intangibles shows it stood at -$123000.0 in 2021, then crashed by 197.56% to -$366000.0 in 2022, then soared by 1579.78% to $5.4 million in 2023, then tumbled by 173.56% to -$4.0 million in 2024, then soared by 120.91% to $833000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Amortization - Intangibles were $833000.0 in Q4 2025, $833000.0 in Q3 2025, and $833000.0 in Q2 2025.